Mirum Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Mirum Pharmaceuticals Inc cash flow-to-debt ratio. Mirum Pharmaceuticals Inc (MIRM) has a Cash Flow-to-Debt Ratio of -0.35x as of March 2026, meaning its operating cash flow of $-228.76 Million could theoretically repay 0% of its total liabilities ($648.42 Million) in one year. Check MIRM cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mirum Pharmaceuticals Inc (2018–2025)
Cash flow-to-debt ratio of Mirum Pharmaceuticals Inc from 2018 to 2025. Historical debt coverage capacity for Mirum Pharmaceuticals Inc across 8 annual periods. Check MIRM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Mirum Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Mirum Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Mirum Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Mirum Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | $55.83 Million | $528.12 Million | ▲ +355.7% |
| 2024 | 0.02x | $10.32 Million | $445.11 Million | ▲ +113.0% |
| 2023 | -0.18x | $-70.94 Million | $397.95 Million | ▲ +68.7% |
| 2022 | -0.57x | $-120.14 Million | $210.87 Million | ▲ +25.1% |
| 2021 | -0.76x | $-132.76 Million | $174.44 Million | ▲ +41.2% |
| 2020 | -1.30x | $-89.08 Million | $68.77 Million | ▲ +46.2% |
| 2019 | -2.41x | $-39.36 Million | $16.36 Million | ▼ -40077.2% |
| 2018 | -0.01x | $-373.00K | $62.30 Million | — |